| ID | Name | CAS | Properties |
logPoct/wat |
| 113-158-1 |
5-P-anisyl-7-oxo-1,2,3a,4-tetrazaindene
|
|
2 | 0.611 |
| 113-161-7 |
1,3-Propanediol, 2,2-dimethyl-, bis(cyclic 2,2-dimethyltrimethylene phosphite)
|
|
2 | 4.646 |
| 113-166-2 |
1-Cyclohexene-1-carboxylic acid, 3,4,5-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester, [3R-(3«alpha»,4«alpha»,5«beta»)]-
|
55520-78-0 |
2 | 5.355 |
| 113-282-3 |
Oxadiazole, 1,2,4-, 5-(4-butoxyphenyl)-3-(5-nitrofuran-2-yl)-
|
|
2 | 4.084 |
| 113-399-4 |
Carbamic acid, n-methyl, n-nitroso-, 4[2-(n'-methyl-n'-nitroso-ureido)ethyl]phenyl ester
|
|
2 | 1.664 |
| 113-585-7 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)isohexyloxy-
|
|
2 | 5.248 |
| 113-687-4 |
4-Aminobenzoic acid, N- pentafluoropropionyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 7.384 |
| 113-716-1 |
Theanderose: aD-Gclp(1->6)-aDGlcp(1->2)-DFru, oxime-TMS
|
|
2 | 12.837 |
| 113-796-3 |
9-Oxo-11-octadecenoic acid, 13-hydroxy, PFBO, TMS, methyl ester, # 2
|
|
2 | 8.905 |
| 113-797-2 |
4-Pregnen-3-«beta»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 7.638 |
| 113-823-2 |
Pyrimidine, 6-amino-4-hydroxy-5-(3-carboxypropionyl)amino, TMS
|
|
2 | 4.034 |
| 113-932-1 |
9H-Purine, 9-[2,3-bis-O-(trimethylsilyl)-«beta»-D-ribofuranosyl]-6-(trimethylsiloxy)-2-[(trimethylsilyl)amino]-, 5'-[bis(trimethylsilyl) phospate]
|
32653-15-9 |
2 | 8.452 |
| 113-943-9 |
6-Bromo-3-phenyl-3,4-dihydro-2h-1,3-benzoxazine
|
|
2 | 3.806 |
| 113-980-8 |
D-(-)-Citramalic acid, tert-butyldimethylsilyl ether, bis(tert-butyldimethylsilyl) ester
|
|
2 | 7.254 |
| 114-028-4 |
2,2,4,4,6,8,10-heptamethyl-6,8,10-tri(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 4.444 |
| 114-074-3 |
2-Amino-4,6-dihydroxypyrimidine, N-trimethylsilyl-, bis(trimethylsilyl) ether
|
|
2 | 4.151 |
| 114-110-2 |
3'-Glucosyl-isomaltose: aD-Glcp(1->3)-aDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 114-159-9 |
Silane, diphenylisohexyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 5.038 |
| 114-161-6 |
Silane, diphenylhexyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 5.182 |
| 114-328-1 |
Butanoic acid, 2,2-dimethyl-3-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55530-56-8 |
2 | 3.631 |
| 114-347-0 |
1H-Indole-3-acetic acid, 5-methoxy-1-(trimethylsilyl)-, trimethylsilyl ester
|
|
2 | 4.254 |
| 114-351-5 |
Silane, diphenylhexyloxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 6.027 |
| 114-427-1 |
S-triazolo[1,5-a]pyrimidin-7-ol-, 5-phenyl- (keto form)
|
|
2 | 1.443 |
| 114-490-1 |
5«xi»-Pregnan-11-one, 1«xi»,3«xi»,20«xi»-trihydroxy, EO-TMS
|
|
2 | 8.938 |
| 114-542-3 |
13,14-Dihydro-15-keto-PGF1A, EO-TMS, isomer # 1
|
|
2 | 9.534 |
| 114-573-9 |
6'-Galactosyl-lactose: bD-Galp(1->6)-bDGalp(1->4)-DGlu, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 114-581-0 |
3-hydroxy-4-methylglutamic acid, N(O,S)-isoBOC TBDMS, diastreoisomer 1
|
|
2 | 6.400 |
| 114-646-8 |
2,4,6-trimethyl-2,4,6-tri(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 3.007 |
| 114-723-2 |
15(S)-15-Methyl-PGA2, BO-TMS, isomer # 1
|
|
2 | 9.203 |
| 114-778-2 |
Methyl 5-.beta.-cholan-3-one-24-oate, oxime, TMS # 2
|
|
2 | 7.442 |
| 114-784-5 |
9H-purine, 2,6-dichloro-9-beta-d-ribofuranosyl-, 2',3',5'-triacetate
|
|
2 | 1.457 |
| 114-859-2 |
Pentanoic acid, 3-oxo-2-propyl, enol-bis-TMS, # 1
|
|
2 | 4.680 |
| 114-951-9 |
2-Propenoic acid, 3-[1-(trimethylsilyl)-1H-indol-3-yl]-, trimethylsilyl ester
|
55124-88-4 |
2 | 4.716 |
| 114-952-8 |
L-Tryptophan, N,1-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 8.549 |
| 114-953-7 |
27-nor-5-«beta»-Cholestan-3-«alpha»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 2
|
|
2 | 11.165 |
| 114-954-6 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTMTBSi
|
|
2 | 10.239 |
| 114-955-5 |
2,2,4,4,6,8-Hexamethyl-6,8-diphenyl-[1,3 ,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 3.428 |
| 114-956-4 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, EO-TMS
|
|
2 | 7.715 |
| 114-971-7 |
5«beta»-Pregnane-20-one-3«alpha»,21-diol, EO-TMS, # 1
|
|
2 | 7.719 |
| 114-973-5 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)silyloxy)(2,6-dimethylnon-1-en-3-yn-5-yloxy)-
|
|
2 | 7.208 |
| 114-979-9 |
3,20-Dioxo-11«beta»,18-epoxy-17«alpha»,18,21-trihydroxy-4-pregnene, MO-TMS, anti
|
|
2 | 7.562 |
| 115-079-7 |
Cholanic acid, 3.alpha.,6.alpha.,7.alpha.-trihydroxy, Me-DMES
|
|
2 | 10.285 |
| 115-175-0 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprost-13-enoic acid, EO-TMS # 1
|
|
2 | 9.700 |
| 115-211-9 |
Phthalimide, n-[4-(tetrahydro-2-oxo-2h-1,3-oxazin-3-yl)butyl]-
|
23545-36-0 |
2 | 1.905 |
| 115-212-8 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 1)
|
|
2 | 6.206 |
| 115-214-6 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 2)
|
|
2 | 6.206 |
| 115-339-8 |
3H-1,4-benzodiazepine, 1,2,4,5-tetrahydro- 4-(p-methoxyphenyl)-1-methyl-
|
|
2 | 3.152 |
| 115-364-0 |
4,6-Pteridinediol, 2-trimethylsilamino-, O,O-bis(trimethylsilyl)-, ether
|
|
2 | 4.094 |
| 115-511-6 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)ethoxy-
|
|
2 | 4.126 |
| 115-671-9 |
13,14-Dihydro-15-keto-PGF2A, MO-TMS, isomer # 1
|
|
2 | 8.920 |
| 115-711-4 |
3-Furoic acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
2 | 3.594 |
| 115-766-4 |
Prosta-5,8(12),13-trien-1-oic acid, 9-(methoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (5Z,13E,15S)-
|
56009-42-8 |
2 | 7.931 |
| 115-789-9 |
Ethylthiosulfuric acid, 2-[(1,7,7-trimethylbicyclo[2.2.1.]hept-2-yl)-amino]-
|
|
2 | 0.958 |
| 115-811-3 |
5«xi»-Pregnan-11-one, 1«xi»,3«xi»,20«xi»-trihydroxy, TMSO-TMS
|
|
2 | 9.753 |
| 115-939-2 |
3'-Glucosyl-isomaltose: aD-Glcp(1->3)-aDGlcp(1->6)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 14.359 |
| 116-000-2 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, EO-TMS # 1
|
|
2 | 10.307 |
| 116-021-9 |
2,6(Or 5)-pyrazinediol, 3-amino-5(or 6)-methyl-
|
116659-94-0 |
2 | -1.116 |
| 116-033-6 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, MO-TMS # 1
|
|
2 | 9.916 |
| 116-104-7 |
Trimethylsilyl 4-(2,2-dimethyl-1-(trimethylsilyl(hydrazino)-4-oxo-butanoate
|
|
2 | 2.285 |
| 116-191-1 |
D-Glucuronic acid, 2,4,5-tris-O-(trimethylsilyl)-, lactone
|
|
2 | 2.771 |
| 116-209-1 |
3-Deoxy-2-C-hydroxymethyl-erythro-pentonic acid, 1,4-lactone, TMS
|
|
2 | 3.595 |
| 116-291-0 |
13,14-Dihydro-6,15-diketo-PGF1A, MO-TMS, isomer # 2
|
|
2 | 8.757 |
| 116-311-7 |
Phosphonothioic acid, methyl-, o,o-bis-3,3-dimethyl butyl ester
|
|
2 | 4.831 |
| 116-315-3 |
5«beta»-Pregnan-3«alpha»,11«beta»,17«alpha»,21-tetrol-20-one, MO-tetrakis-TMS
|
|
2 | 9.133 |
| 116-401-7 |
Clostebol M (Androst-4-en-4-chloro-3A-ol-17-one), TMS
|
|
2 | 8.081 |
| 116-532-2 |
2-Propenoic acid, 2-[(trimethylsilyl)oxy]-3-[4-[(trimethylsilyl)oxy]phenyl]-, trimethylsilyl ester
|
27750-74-9 |
2 | 5.471 |
| 116-627-7 |
2-Aminobenzoic acid, N-heptafluorobutyryl-, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 8.020 |
| 116-734-8 |
2,2,4,4,6,6,8,10-octamethyl-8,10-di(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 4.160 |
| 116-783-4 |
Glucaric acid, 2,3,5-tris-O-(trimethylsilyl)-, «gamma»-lactone, 6-(trimethylsilyl) ester
|
56272-60-7 |
2 | 3.950 |
| 116-832-9 |
Glycine, N-(2-methyl-1-oxobutyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55530-60-4 |
2 | 3.074 |
| 116-939-1 |
Gentianose: bD-Gclp(1->6)-aDGlcp(1->2)-DFru, oxime-TMS
|
|
2 | 12.837 |
| 116-953-5 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprost-13-enoic acid, MO-TMS # 1
|
|
2 | 9.310 |
| 116-960-7 |
1-Methyl-N,N-bis(trimethylsilyl)-4-[(trimethylsilyl)oxy]-1H-imidazol-2-amine
|
|
2 | 4.110 |
| 116-961-6 |
N,9-bis(Trimethylsilyl)-6-[(trimethylsilyl)oxy]-9H-purin-2-amine
|
|
2 | 3.970 |
| 116-985-0 |
13,14-Dihydro-15-keto-PGF2A, EO-TMS, isomer # 1
|
|
2 | 9.310 |
| 117-044-3 |
bis-(2,3-Dihydroxypropyl)-(2-hydroxy-1-hydroxyethyl)amine, hexakis-TMS
|
|
2 | 7.503 |
| 117-133-4 |
4-Chloro-N-(2-hydroxypropionyl)-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 3.932 |
| 117-205-4 |
Pregnan-20-one, 3,17,21-tris[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
57397-20-3 |
2 | 8.260 |
| 117-207-2 |
5«beta»-Androstane-3,17-dione, bis-TMS, (3-en)
|
|
2 | 7.720 |
| 117-233-3 |
Silane, (5«beta»-pregnane-3«alpha»,11«beta»,20«beta»-triyltrioxy)tris[trimethyl-
|
33287-46-6 |
2 | 8.935 |
| 117-298-2 |
Glycine, N-(3-methyl-1-oxobutyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55520-90-6 |
2 | 3.074 |
| 117-369-3 |
4H-Pyran-4-one, 5-[(trimethylsilyl)oxy]-2-[[(trimethylsilyl)oxy]methyl]-
|
55557-21-6 |
2 | 3.205 |
| 117-471-9 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 2
|
|
2 | 12.712 |
| 117-538-5 |
1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one
|
1021-25-6 |
2 | 0.702 |
| 117-552-9 |
O-ethyl-o-(2,4,6-trichlorophenyl)-n-ethylamido thiophosphate
|
|
2 | 4.896 |
| 117-696-0 |
Cholan-24-oic acid, 3-oxo-7,12-bis[(trimethylsilyl)oxy]-, methyl ester, (5«beta»,7«alpha»,12«alpha»)-
|
15093-99-9 |
2 | 7.464 |
| 117-718-5 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, MO TMS # 2
|
|
2 | 9.086 |
| 117-731-0 |
5-«alpha»-Pregnan-3-«beta»,16-«alpha»,20-«beta»,21-tetrol, MeTMS
|
|
2 | 9.767 |
| 117-778-9 |
3-Aminobenzoic acid, N- heptafluorobutyryl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 8.020 |
| 117-782-4 |
3-Aminobenzoic acid, N,N-bis(acetyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 3.748 |
| 117-784-2 |
4-Aminobenzoic acid, N- heptafluorobutyryl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 8.020 |
| 117-958-9 |
15(S)-15-Methyl-PGD2, MO-TMS, isomer # 1
|
|
2 | 9.086 |
| 118-076-7 |
3-Aminobenzoic acid, N- acetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 6.207 |
| 118-096-5 |
Formamide, n-(4-amino-6-(benzylthio)-5-pyrimidinyl)-n-ethyl-
|
92296-30-5 |
2 | 2.334 |
| 118-164-9 |
Prosta-5,8(12),13-trien-1-oic acid, 9-(ethoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (5Z,13E,15S)-
|
56009-44-0 |
2 | 8.321 |
| 118-182-9 |
13,14-Dihydro-6,15-diketo-PGF1A, MO-TMS, isomer # 1
|
|
2 | 8.757 |
| 118-307-0 |
2,2,4,6-tetramethyl-4,6-di(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 2.723 |
| 118-446-6 |
2,4-dimethyl-2,4,6,6-tetraphenyl-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 3.265 |
| 118-450-1 |
1H-Purine-2,6,8(3H)-trione, 4,9-dihydro-1,3,4,9-tetrakis(trimethylsilyl)-
|
55530-45-5 |
2 | 4.206 |
| 118-501-4 |
3«alpha»,5«beta»,7«alpha», 17«alpha»-tetrahydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 13.389 |
|
« Previous Results
Next Results »
|